Johan Christenson - Net Worth and Insider Trading
Johan Christenson Net Worth
The estimated net worth of Johan Christenson is at least $82 Million dollars as of 2024-12-28. Johan Christenson is the Director of Fusion Pharmaceuticals Inc and owns about 3,807,247 shares of Fusion Pharmaceuticals Inc (FUSN) stock worth over $82 Million. Johan Christenson is also the Director of Aprea Therapeutics Inc and owns about 118,305 shares of Aprea Therapeutics Inc (APRE) stock worth over $398,688. Details can be seen in Johan Christenson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Johan Christenson has not made any transactions after 2020-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Johan Christenson
Johan Christenson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Johan Christenson owns 3 companies in total, including Aprea Therapeutics Inc (APRE) , Fusion Pharmaceuticals Inc (FUSN) , and Tengion Inc (TNGNQ) .
Click here to see the complete history of Johan Christenson’s form 4 insider trades.
Insider Ownership Summary of Johan Christenson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-06-30 | director |
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-30 | director |
| TNGNQ | Tengion Inc | 2012-10-02 | 10 percent owner |
Johan Christenson Latest Holdings Summary
Johan Christenson currently owns a total of 2 stocks. Among these stocks, Johan Christenson owns 3,807,247 shares of Fusion Pharmaceuticals Inc (FUSN) as of June 30, 2020, with a value of $82 Million and a weighting of 99.52%. Johan Christenson also owns 118,305 shares of Aprea Therapeutics Inc (APRE) as of October 7, 2019, with a value of $398,688 and a weighting of 0.48%.
Latest Holdings of Johan Christenson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-30 | 3,807,247 | 21.55 | 82,046,173 |
| APRE | Aprea Therapeutics Inc | 2019-10-07 | 118,305 | 3.37 | 398,688 |
Holding Weightings of Johan Christenson
Johan Christenson Form 4 Trading Tracker
According to the SEC Form 4 filings, Johan Christenson has made a total of 1 transactions in Fusion Pharmaceuticals Inc (FUSN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fusion Pharmaceuticals Inc is the acquisition of 240,000 shares on June 30, 2020, which cost Johan Christenson around $4 Million.
According to the SEC Form 4 filings, Johan Christenson has made a total of 0 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 13,333 shares on October 7, 2019, which cost Johan Christenson around $4 Million.
Insider Trading History of Johan Christenson
- 1
Johan Christenson Trading Performance
GuruFocus tracks the stock performance after each of Johan Christenson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Johan Christenson is 41.96%. GuruFocus also compares Johan Christenson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Johan Christenson within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Johan Christenson's insider trading performs compared to the benchmark.
Performance of Johan Christenson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.57 | | | | | |
| Relative Return to S&P 500(%) | -6.42 | | | | | |
Johan Christenson Ownership Network
Johan Christenson Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Johan Christenson is the director of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Johan Christenson made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 23,728 shares made by Marc Duey , and a net purchase of 1,510 shares made by John P. Hamill .
In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 59,320 shares were bought by its insiders, resulting in a net purchase of 52,858 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Johan Christenson Mailing Address
Above is the net worth, insider trading, and ownership report for Johan Christenson. You might contact Johan Christenson via mailing address: C/o Odlander, Fredrikson & Co. Ab, Strandvagen 5b, Stockholm V7 Se-114 51.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
